Detalhe da pesquisa
1.
Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia.
Pediatr Blood Cancer
; 68(7): e28946, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33694257
2.
Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors.
Front Oncol
; 11: 660892, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168987
3.
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
Blood Adv
; 5(14): 2901-2908, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297046